🤖 The AI Bubble Isn’t as Bubbly as It Looks Right Now?

🫧 The AI Bubble Isn’t as Bubbly as It Looks Right Now?

🩻 AI Spots Pancreatic Cancer 3 Years Early

📍 6 AI Stock Sectors

🛠️ 5 Trending Tools

🥪 4 Brief Bites

💰 3 Funding Frontlines

💼 4 Job Opportunities

The Magnificent 7 make up approximately 33.7% of the S&P 500 Index, heavily influencing the U.S. financial markets and investor sentiment. NVIDIA alone makes up about 7.3% of the S&P 500 Index. For context, that means about 7.3% of every dollar invested in the S&P 500 Index goes to NVIDIA.

The four major “AI hyperscalers” within the Magnificent 7, which include Google, Amazon, Microsoft, and Meta, plan to spend a combined $725 billion on CapEx this year, up 77% from last year’s record-breaking spend.

To put this into perspective, with 2026 inflation-adjusted dollars, the original construction of the U.S. Interstate Highway System cost about $634 billion. In other words, the U.S. built a nationwide transportation network for less than what a handful of “AI hyperscalers” are allocating to AI in 2026.

To justify the price of their stocks today, the Magnificent 7 must reportedly generate $3 trillion in combined annual revenue. In other words, AI must become the biggest money-making engine in the history of capitalism, bigger than every other major Big Tech company combined today, to validate these numbers.

The Magnificent 7 haven’t quite reached the $3 trillion in combined annual revenue, but they’re getting remarkably close. As of right now, their combined annual revenue is estimated to be in the “mid-$2 trillion range” based on available Q1 FY2026 earnings and current TTM estimates.

The Magnificent 7 are increasingly issuing debt or utilizing cash reserves to fund AI investments. In other words, they’re borrowing from a future that doesn’t exist yet. The multi-trillion-dollar debate around The AI Bubble revolves around this critical question: “Is AI truly a transformative technology, or an overblown promise?”

So why are the Magnificent 7 continuing to throw money at AI investments? Historically, every major technological revolution has gone through overinvestment phases where the financial markets overreact. But even when the financial cycle dips, the technology cycle continues. Google, Amazon, Microsoft, and Meta believe it’s better to overinvest and survive a correction than to underinvest and miss out.

Pancreatic cancer is a malignant tumor that forms in your pancreas, a gland within your abdomen that aids in digestion. It’s often associated with a delayed diagnosis, as the most common symptoms, which include unexplained weight loss and yellowing of the eyes, aren’t noticeable until it’s already advanced.

“REDMOD” analyzes the subtle tissue architecture of the pancreas, leveraging medical imaging from routine abdominal CT scans to autonomously perform a 40-feature radiomic signature: the extraction of pixel-level features invisible to the human eye that measure the “edge,” “grain,” or “texture” of tissues. These pixel-level features track organ density, which helps flag early signs of pancreatic growth.

It was trained on a multi-hospital cohort of 969 patients with similar abdominal CT scans. Within this cohort, 219 patients had scans that were originally interpreted as normal, but were clinically diagnosed with pancreatic cancer between 3 months and 3 years later.

It reviewed 2,000 routine abdominal CT scans originally interpreted as normal and correctly identified 73% of them as showing “subvisual signs” of pancreatic cancer up to 475 days before a clinical diagnosis. In comparison, only 39% of experienced radiologists correctly performed “preclinical detection” on the same scans.

The five-year survival rate for pancreatic cancer has stalled at 13%, making it one of the deadliest common cancers. It’s the third leading cause of cancer death in the U.S., often referred to as the “silent killer.” This technical turning point provides a path to preventative care, allowing it to be seen while it’s still curable.

Chord raised a $7M Seed Round to turn every data question into action.

Netomi closed a $110M Series C to scale agentic customer service.

Aidoc landed a $150M Series E to unlock clinical AI’s potential.

Tesla (Palo Alto, CA): Software Engineer, AI Inference, Summer 2026

NVIDIA (Santa Clara, CA): Compiler Engineer, Backend, Entry-Level

Hive (San Francisco, CA): Software Engineer, Frontend, Mid-Level

OpenAI (London, UK): Regional Client Partner, Ads Stack, Senior-Level